Literature DB >> 7739703

Isotretinoin for juvenile chronic myelogenous leukemia.

C H Pui, M Aricò.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7739703     DOI： 10.1056/NEJM199506013322216

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Granulocytic sarcoma presenting with severe adenopathy (cervical lymph nodes, tonsils, and adenoids) in a child with juvenile myelomonocytic leukemia and successful treatment with allogeneic bone marrow transplantation.

Authors:  Toshihiko Imamura; Satoshi Matsuo; Takao Yoshihara; Tomohiro Chiyonobu; Kanako Mori; Hiroyuki Ishida; Yasutaka Nishimura; Yasuo Kasubuchi; Mayumi Naya; Akira Morimoto; Shigeyoshi Hibi; Shinsaku Imashuku
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 2.  Juvenile myelomonocytic leukemia.

Authors:  Charlotte Marie Niemeyer; Christian Kratz
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

Review 3.  Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.

Authors:  Ayami Yoshimi; Seiji Kojima; Naoto Hirano
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022

Review 4.  Juvenile myelomonocytic leukemia.

Authors:  Charlotte Marie Niemeyer; Christian Kratz
Journal:  Curr Treat Options Oncol       Date:  2003-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.